Dr Reddy's gets 4 observations from USFDA for Telangana plant

US health regulator has issued four observations after inspecting Dr Reddy's active pharmaceutical ingredients (API) facility in Telangana.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news